These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25317960

  • 21. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.
    Lora-Tamayo J, Parra-Ruiz J, Rodríguez-Pardo D, Barberán J, Ribera A, Tornero E, Pigrau C, Mensa J, Ariza J, Soriano A.
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):66-71. PubMed ID: 24996840
    [Abstract] [Full Text] [Related]

  • 22. Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis.
    Lal Y, Assimacopoulos AP.
    Clin Infect Dis; 2010 Mar 01; 50(5):737-40. PubMed ID: 20121418
    [Abstract] [Full Text] [Related]

  • 23. Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids.
    Chiu SY, Faust AC, Dand HM.
    J Pharm Pract; 2015 Jun 01; 28(3):275-9. PubMed ID: 25657193
    [Abstract] [Full Text] [Related]

  • 24. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin.
    Cobb E, Kimbrough RC, Nugent KM, Phy MP.
    Ann Pharmacother; 2007 Apr 01; 41(4):696-701. PubMed ID: 17374626
    [Abstract] [Full Text] [Related]

  • 25. [Case of acute eosinophilic pneumonia probably induced by minocycline].
    Shimizu T, Shimizu N, Kinebuchi S, Toyama J.
    Nihon Kokyuki Gakkai Zasshi; 2008 Feb 01; 46(2):136-40. PubMed ID: 18318258
    [Abstract] [Full Text] [Related]

  • 26. Clinical characteristics, management, and outcome of eosinophilic pneumonia associated with daptomycin.
    Wu C, Li Z, Wang C, Deng Z.
    Med Clin (Barc); 2023 Jan 05; 160(1):17-22. PubMed ID: 35840367
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Eosinophilic Pneumonia Putatively Induced by Vancomycin: A Case Report.
    Isono T, Sawaguchi H, Kusumoto H, Shiono H.
    Am J Case Rep; 2019 Sep 30; 20():1440-1445. PubMed ID: 31564716
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
    Perrottet N, Steinrücken J, Chan M, Pannatier A, Borens O, Yusuf E, Trampuz A.
    Int J Antimicrob Agents; 2015 Oct 30; 46(4):480-2. PubMed ID: 26235888
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.
    Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.